Found: 41
Select item for more details and to access through your institution.
Retinal ganglion cell degeneration correlates with hippocampal spine loss in experimental Alzheimer's disease.
- Published in:
- Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40478-020-01094-2
- By:
- Publication type:
- Article
Volume‐rendered optical coherence tomography angiography during ocular interventions: Advocating for noninvasive intraoperative retinal perfusion monitoring.
- Published in:
- Journal of Biophotonics, 2022, v. 15, n. 12, p. 1, doi. 10.1002/jbio.202200169
- By:
- Publication type:
- Article
Nicotinamide and WLD<sup>S</sup> Act Together to Prevent Neurodegeneration in Glaucoma.
- Published in:
- Frontiers in Neuroscience, 2017, v. 11, p. 1, doi. 10.3389/fnins.2017.00232
- By:
- Publication type:
- Article
Complement peptide C3a receptor 1 promotes optic nerve degeneration in DBA/2J mice.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Retinal Ganglion Cell Dendritic Atrophy in DBA/2J Glaucoma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0072282
- By:
- Publication type:
- Article
Glial metabolic alterations during glaucoma pathogenesis.
- Published in:
- Frontiers in Ophthalmology, 2023, p. 1, doi. 10.3389/fopht.2023.1290465
- By:
- Publication type:
- Article
Comparison of Glaucoma-Relevant Transcriptomic Datasets Identifies Novel Drug Targets for Retinal Ganglion Cell Neuroprotection.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 17, p. 3938, doi. 10.3390/jcm10173938
- By:
- Publication type:
- Article
Ocular hypertension suppresses homeostatic gene expression in optic nerve head microglia of DBA/2 J mice.
- Published in:
- Molecular Brain, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13041-020-00603-7
- By:
- Publication type:
- Article
Digestion of the glycosaminoglycan extracellular matrix by chondroitinase ABC supports retinal ganglion cell dendritic preservation in a rodent model of experimental glaucoma.
- Published in:
- Molecular Brain, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13041-018-0412-5
- By:
- Publication type:
- Article
A serum protein signature at the time of Uveal Melanoma diagnosis predicts long-term patient survival.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10757-x
- By:
- Publication type:
- Article
A survey of ambulance clinicians' perceptions of recording and communicating patient information electronically.
- Published in:
- British Paramedic Journal, 2021, v. 6, n. 1, p. 1, doi. 10.29045/14784726.2021.6.6.1.1
- By:
- Publication type:
- Article
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma.
- Published in:
- Acta Neuropathologica Communications, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40478-024-01850-8
- By:
- Publication type:
- Article
Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection.
- Published in:
- Acta Neuropathologica Communications, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40478-024-01782-3
- By:
- Publication type:
- Article
Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection.
- Published in:
- Acta Neuropathologica Communications, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40478-024-01777-0
- By:
- Publication type:
- Article
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume.
- Published in:
- Acta Neuropathologica Communications, 2024, v. 12, n. 1, p. 1, doi. 10.1186/s40478-024-01724-z
- By:
- Publication type:
- Article
Pyrroloquinoline quinone drives ATP synthesis in vitro and in vivo and provides retinal ganglion cell neuroprotection.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01642-6
- By:
- Publication type:
- Article
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01513-0
- By:
- Publication type:
- Article
Widespread retina and optic nerve neuroinflammation in enucleated eyes from glaucoma patients.
- Published in:
- Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-022-01427-3
- By:
- Publication type:
- Article
Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma: A Phase 2 Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Opa1 is essential for retinal ganglion cell synaptic architecture and connectivity.
- Published in:
- Brain: A Journal of Neurology, 2012, v. 135, n. 2, p. 493, doi. 10.1093/brain/awr330
- By:
- Publication type:
- Article
Opa1 deficiency in a mouse model of dominant optic atrophy leads to retinal ganglion cell dendropathy.
- Published in:
- Brain: A Journal of Neurology, 2010, v. 133, n. 10, p. 2942, doi. 10.1093/brain/awq218
- By:
- Publication type:
- Article
Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial.
- Published in:
- Clinical & Experimental Ophthalmology, 2020, v. 48, n. 7, p. 903, doi. 10.1111/ceo.13818
- By:
- Publication type:
- Article
Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 6, p. 1, doi. 10.1038/s41419-018-0705-8
- By:
- Publication type:
- Article
Preventing retinal homocysteine dysregulation protects against retinal ganglion cell death.
- Published in:
- Acta Ophthalmologica (1755375X), 2024, v. 102, p. N.PAG, doi. 10.1111/aos.16330
- By:
- Publication type:
- Article
Neuroprotective effects of GLP‐1 receptor agonists and their potential in retinal diseases.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Neuroprotection in Glaucoma: NAD + /NADH Redox State as a Potential Biomarker and Therapeutic Target.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 6, p. 1402, doi. 10.3390/cells10061402
- By:
- Publication type:
- Article
Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 2, p. 295, doi. 10.3390/cells10020295
- By:
- Publication type:
- Article
A multiethnic genome-wide association study of primary open-angle glaucoma identifies novel risk loci.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04555-4
- By:
- Publication type:
- Article
Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma.
- Published in:
- Molecular Neurodegeneration, 2016, v. 11, p. 1, doi. 10.1186/s13024-016-0091-6
- By:
- Publication type:
- Article
GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol.
- Published in:
- BMC Neurology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12883-024-03596-1
- By:
- Publication type:
- Article
The rationale for treating uveal melanoma with adjuvant melatonin: a review of the literature.
- Published in:
- 2022
- By:
- Publication type:
- journal article
NMNAT2 is a druggable target to drive neuronal NAD production.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50354-5
- By:
- Publication type:
- Article
Longitudinal Relationships Between Use of Highly Active Antiretroviral Therapy and Satisfaction With Care Among Women Living With HIV/AIDS.
- Published in:
- American Journal of Public Health, 2006, v. 96, n. 6, p. 1044, doi. 10.2105/AJPH.2005.061929
- By:
- Publication type:
- Article
Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolism.
- Published in:
- Neural Regeneration Research, 2025, v. 20, n. 1, p. 41, doi. 10.4103/NRR.NRR-D-23-01921
- By:
- Publication type:
- Article
Glycolysis and glucose metabolism as a target for bioenergetic and neuronal protection in glaucoma.
- Published in:
- Neural Regeneration Research, 2024, v. 19, n. 8, p. 1637, doi. 10.4103/1673-5374.389638
- By:
- Publication type:
- Article
POLITICAL INFLUENCE AND THE INTERNAL REVENUE SERVICE.
- Published in:
- CATO Journal, 1999, v. 19, n. 2, p. 313
- By:
- Publication type:
- Article
Protrudin functions from the endoplasmic reticulum to support axon regeneration in the adult CNS.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-19436-y
- By:
- Publication type:
- Article
Potential Therapeutic Benefit of NAD + Supplementation for Glaucoma and Age-Related Macular Degeneration.
- Published in:
- Nutrients, 2020, v. 12, n. 9, p. 2871, doi. 10.3390/nu12092871
- By:
- Publication type:
- Article
Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma?
- Published in:
- Frontiers in Neuroscience, 2022, v. 15, p. 1, doi. 10.3389/fnins.2022.824054
- By:
- Publication type:
- Article
Inhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucoma.
- Published in:
- Molecular Neurodegeneration, 2019, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13024-018-0303-3
- By:
- Publication type:
- Article